BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24327111)

  • 1. Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin.
    Shi Z; Guo R; Li W; Zhang Y; Xue W; Tang Y; Zhang Y
    J Mater Sci Mater Med; 2014 Mar; 25(3):723-31. PubMed ID: 24327111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-Modified Poly(malic acid) Graft Polymeric Nanoparticles for Targeted Delivery of Doxorubicin: Synthesis, Characterization and Folate Receptor Expressed Cell Specificity.
    Yang Y; Li N; Nie Y; Sheng M; Yue D; Wang G; Tang JZ; Gu Z
    J Biomed Nanotechnol; 2015 Sep; 11(9):1628-39. PubMed ID: 26485931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin.
    Zhou H; Yu W; Guo X; Liu X; Li N; Zhang Y; Ma X
    Biomacromolecules; 2010 Dec; 11(12):3480-6. PubMed ID: 21028798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid conjugated glycol chitosan micelles for targeted delivery of doxorubicin: preparation and preliminary evaluation in vitro.
    Yu J; Xie X; Wu J; Liu Y; Liu P; Xu X; Yu H; Lu L; Che X
    J Biomater Sci Polym Ed; 2013; 24(5):606-20. PubMed ID: 23565871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate-mediated chondroitin sulfate-Pluronic 127 nanogels as a drug carrier.
    Huang SJ; Sun SL; Feng TH; Sung KH; Lui WL; Wang LF
    Eur J Pharm Sci; 2009 Aug; 38(1):64-73. PubMed ID: 19540339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication and characterization of nuclear localization signal-conjugated glycol chitosan micelles for improving the nuclear delivery of doxorubicin.
    Yu J; Xie X; Zheng M; Yu L; Zhang L; Zhao J; Jiang D; Che X
    Int J Nanomedicine; 2012; 7():5079-90. PubMed ID: 23049255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphiphilic Polymeric Micelles Based on Deoxycholic Acid and Folic Acid Modified Chitosan for the Delivery of Paclitaxel.
    Li L; Liang N; Wang D; Yan P; Kawashima Y; Cui F; Sun S
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid-conjugated polyethylene glycol-coated magnetic nanoparticles for doxorubicin delivery in cancer chemotherapy: Preparation, characterization and cytotoxicity on HeLa cell line.
    Erdem M; Yalcin S; Gunduz U
    Hum Exp Toxicol; 2017 Aug; 36(8):833-845. PubMed ID: 27758842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-responsive folic acid conjugated glycol chitosan nanoparticle for enhanced tumor targeting treatment.
    Jang EH; Shim MK; Kim GL; Kim S; Kang H; Kim JH
    Int J Pharm; 2020 Apr; 580():119237. PubMed ID: 32201251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel hyaluronic acid coated hydrophobically modified chitosan polyelectrolyte complex for the delivery of doxorubicin.
    Chen L; Zheng Y; Feng L; Liu Z; Guo R; Zhang Y
    Int J Biol Macromol; 2019 Apr; 126():254-261. PubMed ID: 30584933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-functional nanocarriers based on iron oxide nanoparticles conjugated with doxorubicin, poly(ethylene glycol) and folic acid as theranostics for cancer therapy.
    Rajkumar S; Prabaharan M
    Colloids Surf B Biointerfaces; 2018 Oct; 170():529-537. PubMed ID: 29966906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimuli-responsive hybrid cluster bombs of PEGylated chitosan encapsulated DOX-loaded superparamagnetic nanoparticles enabling tumor-specific disassembly for on-demand drug delivery and enhanced MR imaging.
    Xie P; Du P; Li J; Liu P
    Carbohydr Polym; 2019 Feb; 205():377-384. PubMed ID: 30446118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-Organized Nanoparticles of Caffeic Acid Conjugated Polysaccharide and Its Anticancer Activity.
    Lee SJ; Choi KC; Kang MS; Oh JS; Jeong YI; Lee HC
    J Nanosci Nanotechnol; 2015 Feb; 15(2):1130-4. PubMed ID: 26353622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugates of TAT and folate with DOX-loaded chitosan micelles offer effective intracellular delivery ability.
    Zhang S; Liu Y; Gan Y; Qiu N; Gu Y; Zhu H
    Pharm Dev Technol; 2019 Feb; 24(2):253-261. PubMed ID: 29688120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cytotoxicity profile and intracellular localisation of doxorubicin-loaded chitosan nanoparticles.
    Souto GD; Farhane Z; Casey A; Efeoglu E; McIntyre J; Byrne HJ
    Anal Bioanal Chem; 2016 Aug; 408(20):5443-55. PubMed ID: 27225177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid-modified Prussian blue/polydopamine nanoparticles as an MRI agent for use in targeted chemo/photothermal therapy.
    Lin X; Cao Y; Li J; Zheng D; Lan S; Xue Y; Yu F; Wu M; Zhu X
    Biomater Sci; 2019 Jul; 7(7):2996-3006. PubMed ID: 31111139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart chitosan-folate hybrid magnetic nanoparticles for targeted delivery of doxorubicin to osteosarcoma cells.
    Amiryaghoubi N; Abdolahinia ED; Nakhlband A; Aslzad S; Fathi M; Barar J; Omidi Y
    Colloids Surf B Biointerfaces; 2022 Dec; 220():112911. PubMed ID: 36274396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate-decorated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting delivery: optimization and in vivo antitumor activity.
    Zhang C; Zhang Z; Zhao L
    Drug Deliv; 2016 Jun; 23(5):1830-7. PubMed ID: 26652055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic nanoparticles self-assembled from amphiphilic chitosan derivatives containing poly(amidoamine) dendrons and deoxycholic acid as a vector for co-delivery of doxorubicin and gene.
    Chen S; Deng J; Zhang LM
    Carbohydr Polym; 2021 Apr; 258():117706. PubMed ID: 33593576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery.
    Al-Nadaf AH; Dahabiyeh LA; Jawarneh S; Bardaweel S; Mahmoud NN
    Pharm Dev Technol; 2021 Jun; 26(5):582-591. PubMed ID: 33729906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.